[Clinical practice guidelines for Fragile X syndrome]
Clinical Genetics Group Of Medical Geneticist Branch Of Chinese Medical Doctor Association, Clinical Genetics Group Of Medical Genetics Branch Of Chinese Medical Association, Genetic Disease Prevention And Control Group Of Professional Committee For Birth Defect Prevention And Control Of Chinese Preventive Medicine Association
Fragile X syndrome (FXS), a common cause of inherited intellectual disability and autism, results from FMR1 gene CGG repeat expansion. Genetic testing guides early diagnosis and treatment for affected families.
Area of Science:
- Genetics
- Neurodevelopmental Disorders
Context:
- Fragile X syndrome (FXS) is the leading monogenic cause of inherited intellectual disability and autism spectrum disorder (ASD).
- Over 99% of FXS cases stem from CGG repeat expansions in the FMR1 gene's 5'-untranslated region.
Purpose:
- To provide a standardized guideline for the diagnosis, treatment, and prevention of FXS.
- To consolidate global research, clinical guidelines, and consensus on FXS management.
Summary:
- FXS presents with cognitive deficits, and physical, behavioral, and psychiatric issues.
- Molecular genetic testing of the FMR1 gene is crucial for early detection and family planning.
- This guideline synthesizes current knowledge for consistent patient care.
Impact:
- Facilitates standardized diagnosis and treatment protocols for Fragile X syndrome.
- Empowers families with genetic knowledge for informed decision-making and prevention strategies.
- Improves clinical management and outcomes for individuals with FXS.
More Related Videos
11:10Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
10:59Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein
Published on: June 6, 2025
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Sex-linked Disorders
Standards of Care II
Standards of Care I
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
